Genesis IBRC India Ltd
Incorporated in 1992, Genesis IBRC India Ltd (Formerly SSK Lifestyles Limited) is in the business of Biotechnology.
- Market Cap ₹ 20.6 Cr.
- Current Price ₹ 15.8
- High / Low ₹ 15.8 / 9.73
- Stock P/E
- Book Value ₹ 7.39
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding is low: 11.3%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | |
---|---|
4.33 | |
4.15 | |
Operating Profit | 0.18 |
OPM % | 4.16% |
0.01 | |
Interest | 0.03 |
Depreciation | 0.09 |
Profit before tax | 0.07 |
Tax % | 128.57% |
-0.03 | |
EPS in Rs | -0.02 |
Dividend Payout % | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 27% |
1 Year: | 41% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | |
---|---|
Equity Capital | 13.00 |
Reserves | -3.39 |
1.48 | |
1.21 | |
Total Liabilities | 12.30 |
2.07 | |
CWIP | 1.30 |
Investments | 0.00 |
8.93 | |
Total Assets | 12.30 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | |
---|---|
1.68 | |
-4.66 | |
3.00 | |
Net Cash Flow | 0.02 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | |
---|---|
Debtor Days | 119.70 |
Inventory Days | 68.92 |
Days Payable | 17.87 |
Cash Conversion Cycle | 170.75 |
Working Capital Days | 399.56 |
ROCE % |
Documents
Announcements
- Reg. 34 (1) Annual Report. 6 Sep
-
Notice Of 32Nd Annual General Meeting (AGM) And Annual Report Of The Company For The F Y 2023-24
6 Sep - Notice of 32nd AGM and Annual Report for FY 2023-24.
- Submission Of Unaudited Financial Results, Statement Of Assets & Liabilities And Cash Flow Statements Etc., As Per The Provisions Of SEBI (LODR) Regulations, 2015-Reg. 14 Aug
-
Disclosure Under Regulation 32(1) Of SEBI (LODR) Regulations, 2015
14 Aug - Disclosure under SEBI regulations; no funds raised.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.08.2024
14 Aug - Approved Q1 results and director reappointments.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1]
a) Aquaculture Probiotic: Proteomix Protein Balanced Gel, Yuccagen Ammonia Controller, Growfast Gen Single Cell Protein, Progutgen Aquaculture Gut Probiotic, Rhodogen PS -Water Probiotic
b) Aqua Feed Supplement: Moultigen Aqua EDTA Aqua Culture, Vitagen C Aqua Culture and Zeo-Gen Multi Mineral Additive Granules from India
c) Aquaculture Water Sanitizer: Sangen- Broad Spectrum Sanitizer
d) Soil Probiotic: Genpro Wat Soil Probiotic
e) Aquaculture: Vibrio Controller In Shrimp Culture